Biotronik SE had three patents in artificial intelligence during Q4 2023. The patent filed by Biotronik SE & Co KG in Q4 2023 is for a device that detects signals from a human or animal organism by analyzing signal segments, measuring signal swings, and classifying the organism’s state as physiological or pathophysiological based on the analysis. GlobalData’s report on Biotronik SE gives a 360-degreee view of the company including its patenting strategy. Buy the report here.

Smarter leaders trust GlobalData

Report-cover

Data Insights Biotronik SE & Co KG - Company Profile

Buy the Report

Data Insights

The gold standard of business intelligence.

Find out more

Biotronik SE grant share with artificial intelligence as a theme is 0% in Q4 2023. Grant share is based on the ratio of number of grants to total number of patents.

Recent Patents

Application: Device for detecting a signal from a human or animal organism (Patent ID: US20230405334A1)

The patent by Biotronik SE & Co KG describes a device for detecting signals from a human or animal organism to classify the physiological or pathophysiological state of the organism. The device involves detecting the signal in a time-dependent manner, subdividing it into blocks, determining a measure for signal swing in each block, calculating a quotient based on the measure, and comparing it with threshold values to classify the organism's state. The device can be used for cardiac signal detection and stimulation, with the ability to adjust block widths in different sections, adapt segment lengths based on previous results, and use additional variables like heart rate for classification.

Furthermore, the patent includes claims for an implantable medical device with a processor, storage unit, and detection unit, a computer program product for carrying out the signal processing steps, and a method for signal processing involving detecting, segmenting, measuring, calculating, and comparing signal swings to classify the organism's state. The device can also detect various parameters like electrical signals, pressure, temperature, and biochemical markers, and initiate or prevent therapeutic treatments based on the classification results. Additionally, the device can stimulate cardiac regions based on the classification and includes features like overlapping signal segments, heart rate estimators, and the use of multiple variables for classification.

To know more about GlobalData’s detailed insights on Biotronik SE, buy the report here.

Data Insights

From

The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.

GlobalData

GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.

GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies across the world’s largest industries.